Posted On: 06/01/2014 6:03:41 PM
Post# of 63759

$CTDH. 7-bagger & Ascending triangle & Pr.
Website
CTD Holdings, Inc., a manufacturer of cyclodextrins, (OTCQB:
CTDH), reported product sales of $560,325 for the first quarter
ended March 31, 2014. The Trappsol® Cyclo™ orphan drug product
generated first-quarter sales of $418,000, a 97% increase from the
same period a year ago. Cash increased to $873,000 during the
first quarter due to strong sales and $500,000 raised in a private
placement of equity. news release 2014-05-14 15:01 ET
10-Q 5/9/14
O/S shares 52,562,355
recent trades
Stockwatch
% Buy Opinion (composite)

Website
CTD Holdings, Inc., a manufacturer of cyclodextrins, (OTCQB:
CTDH), reported product sales of $560,325 for the first quarter
ended March 31, 2014. The Trappsol® Cyclo™ orphan drug product
generated first-quarter sales of $418,000, a 97% increase from the
same period a year ago. Cash increased to $873,000 during the
first quarter due to strong sales and $500,000 raised in a private
placement of equity. news release 2014-05-14 15:01 ET
10-Q 5/9/14
O/S shares 52,562,355
recent trades
Stockwatch


% Buy Opinion (composite)


Scroll down for more posts ▼